Is Pulmonary Involvement a Distinct Phenotype of Post-COVID-19?

Area of Science:

• Pulmonology
• Infectious Diseases
• Internal Medicine

Background:

• COVID-19 infection frequently leads to persistent symptoms, collectively known as post-COVID-19 condition (PCC).
• Common PCC symptoms include fatigue, dyspnea, myalgia, and mental distress.
• This study investigated clinical features of PCC, differentiating between patients with and without pulmonary involvement.

Purpose of the Study:

• To identify clinical characteristics associated with post-COVID-19 condition.
• To compare patients with and without pulmonary involvement following COVID-19.
• To explore how pulmonary lesions influence the presentation of PCC.

Main Methods:

• A cohort of 282 patients assessed up to 12 weeks post-COVID-19 recovery.
• Data collection included acute disease course, medical history, clinical symptoms, and follow-up examinations.
• Pulmonary function tests, radiographic studies, and laboratory tests were performed; patients were grouped by presence or absence of pulmonary lesions.

Main Results:

• Patients with pulmonary involvement were older, more frequently male, had higher rates of hospitalization, and were more likely to be current or former smokers.
• Significant correlations were found between pulmonary involvement and hypertension, liver failure, dyspnea, myalgia, headache, sleeplessness, impaired pulmonary function (FVC, TLCO, RV, TLC), and specific laboratory markers.
• Age, male sex, smoking history, hospitalization, hypertension, liver failure, and specific symptoms/test results were associated with pulmonary involvement in PCC.

Conclusions:

• Initial pulmonary involvement significantly impacts the clinical presentation of post-COVID-19 condition.
• Identifying pulmonary involvement can aid in tailoring clinical management strategies for individuals with PCC.
• Understanding these differences allows for more personalized and effective patient care approaches.